Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
CONCLUSION: The performance of regadenoson in inducing maximal hyperemia was comparable to that of adenosine. There was excellent correlation between the FFR measurements by both the agents. The use of adenosine, was however associated with higher risk of adverse events and longer time to FFR compared to regadenoson.PMID:35702325 | PMC:PMC9157604 | DOI:10.4330/wjc.v14.i5.319 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - June 15, 2022 Category: Cardiology Authors: Gauravpal Singh Gill Akshaya Gadre Arun Kanmanthareddy Source Type: research
